Biotech

All Articles

BioAge eyes $180M from IPO, exclusive positioning for excessive weight tests

.BioAge Labs is actually considering about $180 million in first profits coming from an IPO and also...

Merck's LAG-3 combination falls short colon cancer stage 3 research study

.A try through Merck &amp Co. to open the microsatellite secure (MSS) metastatic colon cancer cells ...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Allies has closed a fund of 180 million europeans ($ 200 million), cash that wil...

BioAge generates $198M from IPO as excessive weight biotech joins Nasdaq

.BioAge Labs is generating just about $200 million through its own Nasdaq IPO this morning, along wi...

Acadia delivers BMS veterinarian on board as CEO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant leadership hirings, firings as...

Cassava spends $40M over presumably confusing Alzheimer's update

.Cassava Sciences has consented to spend $40 thousand to deal with an examination into insurance cla...

Merck bags possibilities on Evaxion's AI-designed injection prospects

.Merck &amp Co. has gotten possibilities on pair of Evaxion Biotech injection candidates, paying out...

Enanta's RSV antiviral crushes viral load in obstacle study

.Enanta Pharmaceuticals has connected its respiratory system syncytial virus (RSV) antiviral to cons...

Biogen containers SAGE-324 cooperation after important tremor fail

.Biogen has conducted the final rites to its partnership with Sage Rehabs on SAGE-324, junking the c...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout credit ratings

.On the exact same time that some Parkinson's condition medications are being called into question, ...